Tuesday, March 24, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
No Result
View All Result

These healthcare stocks should thrive in 2022

Daily Remedy by Daily Remedy
November 25, 2021
in
0

As the COVID-19 pandemic recedes, routine doctor and hospital visits, along with deferred medical procedures such as cataract surgery and heart valve replacements, are returning to normal.

The pandemic has been a global tragedy, but if there is one silver lining it is that the miraculous development of effective COVID-19 vaccines in less than a year is helping to usher in a golden age for the pharmaceutical and health sciences industries.

“We’re seeing a revolution today in vaccine development,” says Andy Acker, manager of Janus Henderson Global Life Sciences.

Source: Kiplinger

https://www.kiplinger.com/investing/stocks/stocks-to-buy/603819/these-health-care-stocks-should-thrive-in-2022

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

summary This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices. key topics Deceptive pricing strategies in healthcare The role of brand perception and pricing manipulation The concept of drip pricing and hidden costs The rise of healthcare consumerism and patient agency Strategies for patients to identify and avoid deceptive practices Chapters 00:00 The Evolution of the GLP-1 Telemedicine Market 01:12 How Pricing Is Obscured and Perceived Discounts Are Created 02:11 TrumpRx: Coupon Aggregator or Discount Store? 03:12 Why Price Deception Thrives in Healthcare 04:12 The Membership Fee Illusion and Hidden Costs 05:10 Brand Recognition and Drip Pricing Strategies 06:17 The Impact of Brand and Anchor Pricing on Perceived Value 07:16 The Role of Price Drip Strategies in Healthcare Pricing 08:15 The Rise of Healthcare Consumerism and Patient Agency 09:14 How to Protect Yourself from Deceptive Pricing Practices 10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

No Result
View All Result

© 2026 Daily Remedy